Bausch & Lomb Corp
For the period ended Dec 31, 2024. Filed Feb 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 19, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
We own and lease a number of important properties. Our headquarters are located in Vaughan, Ontario, Canada. We own several manufacturing facilities throughout the United States. We also own or have an interest in manufacturing plants or other properties outside the United States, including in Mexico, and certain countries in Europe, the Middle East, Asia and South America.
We consider our facilities to be in satisfactory condition and suitable for their intended use, although some limited investments to improve our manufacturing and other related facilities are contemplated, based on the needs and requirements of our business. Our administrative, marketing, research/laboratory, distribution and warehousing facilities are located in various parts of the world. We co-locate our R&D activities with our manufacturing at the plant level in a number of facilities. Our scientists, engineers, quality assurance/quality control professionals and manufacturing technicians work side-by-side in designing and manufacturing products that fit the needs and requirements of our customers, regulators and business units. We believe that we have sufficient facilities to conduct our operations. The following are our principal properties, including the segments of our business that use each property:
| Location | Purpose | Segment | OwnedorLeased | ApproximateSquareFootage |
|---|---|---|---|---|
| Vaughan, Ontario, Canada | Corporate headquarters and distribution facility | All Segments | Leased | 66,000 |
| Bridgewater, New Jersey | Administration shared with BHC | All Segments | Leased | 310,000 |
| Rochester, New York | Offices, R&D and manufacturing facility | Pharmaceuticals + Vision Care | Owned | 953,000 |
| Waterford, Ireland | R&D and manufacturing facility | Vision Care | Owned | 500,000 |
| Woodruff, South Carolina | Distribution facility | Vision Care | Leased | 432,000 |
| Jinan, China | Offices and manufacturing facility | Pharmaceuticals + Vision Care | Owned | 418,000 |
| Berlin, Germany | R&D, manufacturing, distribution and office facility | Pharmaceuticals | Owned | 339,000 |
| Greenville, South Carolina | Manufacturing facility | Vision Care | Owned | 314,000 |
| Lynchburg, Virginia | Offices and distribution facility | Vision Care | Owned | 224,000 |
| Aubenas, France | Offices, manufacturing and warehouse facility | Pharmaceuticals | Owned | 193,000 |
| Tampa, Florida | R&D and manufacturing facility | Pharmaceuticals | Owned | 171,000 |
| St. Louis, Missouri | Offices, R&D and manufacturing facility | Surgical | Owned | 140,000 |
| Macherio, Italy | Offices, manufacturing and warehouse facility | Vision Care | Owned | 119,000 |
| Clearwater, Florida | R&D and manufacturing facility | Surgical | Owned | 102,000 |
| Beijing, China | Manufacturing facility | Vision Care | Owned | 97,000 |
| Eppelheim, Germany | Manufacturing facility | Surgical | Leased | 78,000 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.